Skip to content
HowShorted

Lumentum Holdings Inc. short interest in 2022

In 2022, Lumentum Holdings Inc.'s disclosed short interest ran from 9.40% of shares outstanding on 14 Jan 2022 to 9.23% on 30 Dec 2022, a change of -0.17 percentage points. The year's high was 12.94% on 13 May 2022 and its low 8.28% on 28 Feb 2022, averaging 10.47% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.27 days on 29 Jul 2022. Full history: Lumentum Holdings Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Lumentum Holdings Inc. in 2022

2022 in figures

Start of year
9.40% (14 Jan 2022)
End of year
9.23% (30 Dec 2022)
Change
-0.17 pp
High
12.94% (13 May 2022)
Low
8.28% (28 Feb 2022)
Average
10.47%
Highest days to cover
15.27 (29 Jul 2022)
SEC filings marked
8

Every report in 2022

Lumentum Holdings Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20229.40%9.30
31 Jan 20228.51%6.74
15 Feb 20228.62%4.3510-Q filed, results (8-K)
28 Feb 20228.28%6.68
15 Mar 202210.57%4.87
31 Mar 202210.52%10.97
14 Apr 202210.30%10.78
29 Apr 202211.28%11.16
13 May 202212.94%5.2510-Q filed, results (8-K)
31 May 202212.19%10.46
15 Jun 202211.58%10.53
30 Jun 202211.44%7.72
15 Jul 202211.68%13.84
29 Jul 202211.09%15.27
15 Aug 202210.94%11.33
31 Aug 202211.35%7.81results (8-K), 10-K filed
15 Sep 202211.03%10.26
30 Sep 202211.37%9.22
14 Oct 202211.00%10.02
31 Oct 202210.65%10.91
15 Nov 20229.09%3.2010-Q filed, results (8-K)
30 Nov 20229.07%5.92
15 Dec 20229.24%6.25
30 Dec 20229.23%6.64

See also: Lumentum Holdings Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.